Molecular Genetics of Endometrial Carcinoma

  • Lora Hedrick Ellenson

Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 943)

Table of contents

  1. Front Matter
    Pages i-xi
  2. Introduction

    1. Front Matter
      Pages 1-1
    2. Ashley S. Felix, Hannah P. Yang, Daphne W. Bell, Mark E. Sherman
      Pages 3-46
    3. Sigurd F. Lax
      Pages 75-96
  3. Molecular Profiling

    1. Front Matter
      Pages 97-97
    2. Christopher J. Walker, Paul J. Goodfellow
      Pages 99-118
    3. Matthieu Le Gallo, Fred Lozy, Daphne W. Bell
      Pages 119-148
    4. Nuria Eritja, Andree Yeramian, Bo-Juen Chen, David Llobet-Navas, Eugenia Ortega, Eva Colas et al.
      Pages 149-207
  4. Mouse Models

    1. Front Matter
      Pages 209-209
    2. Christopher G. Peña, Diego H. Castrillón
      Pages 211-241
    3. Tae Hoon Kim, Jung-Yoon Yoo, Jae-Wook Jeong
      Pages 243-259
    4. Ayesha Joshi, Lora Hedrick Ellenson
      Pages 261-273
  5. Back Matter
    Pages 275-281

About this book


This comprehensive text provides a much-needed review of a disease that is currently garnering the interest of molecular biologists, translational scientists, and clinicians. The volume includes emerging developments in the molecular genetics of endometrial carcinoma. In addition to covering the basic genetics of endometrial carcinoma, chapters also cover a wide range of signaling pathways implicated in endometrial carcinoma. A section of the book includes a number of genetically engineered mouse models, which contribute to understanding the role of various genetic alterations in the development and progression of endometrial carcinoma.  These models also provide preclinical models for developing effective targeted therapeutic approaches. Endometrial carcinoma is the most common malignancy of the female genital tract in the United States and the number of cases continues to increase around the world. This book is meant to serve as a resource for a wide range of scientists, from molecular geneticists to signal transduction biologists, as well as to both clinicians and scientists interested in developing targeted therapeutic approaches for women with endometrial carcinoma.


PTEN/ PI3K endometrial cancer next generation sequencing signaling pathways molecular genetics

Editors and affiliations

  • Lora Hedrick Ellenson
    • 1
  1. 1.Department of Pathology and Laboratory MedicineWeill Cornell MedicineNew YorkUSA

Bibliographic information

Industry Sectors
Health & Hospitals
Oncology & Hematology
Consumer Packaged Goods